Siu LL - Search Results

1

A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors.

Chen TW, Razak AR, Bedard PL, Siu LL, Hansen AR. Chen TW, et al. Among authors: siu ll. Ann Oncol. 2015 Sep;26(9):1824-1829. doi: 10.1093/annonc/mdv182. Epub 2015 Apr 17. Ann Oncol. 2015. PMID: 25888611 Review.

2

Influence of age on the treatment of limited-stage small-cell lung cancer.

Siu LL, Shepherd FA, Murray N, Feld R, Pater J, Zee B. Siu LL, et al. J Clin Oncol. 1996 Mar;14(3):821-8. doi: 10.1200/JCO.1996.14.3.821. J Clin Oncol. 1996. PMID: 8622030

3

Other chemotherapy regimens including mitoxantrone and suramin.

Siu LL, Moore MJ. Siu LL, et al. Semin Urol Oncol. 1997 Feb;15(1):20-7. Semin Urol Oncol. 1997. PMID: 9050136 Review.

4

Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.

Siu LL, Chapman W, Moore MJ. Siu LL, et al. Am J Clin Oncol. 1997 Dec;20(6):558-61. doi: 10.1097/00000421-199712000-00004. Am J Clin Oncol. 1997. PMID: 9391539

5

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks.

Siu LL, Oza AM, Eisenhauer EA, Firby PS, Thiessen JJ, Michael M, Wainman N, Manzo J, Feld R, Goldberg RA, Moore MJ. Siu LL, et al. J Clin Oncol. 1998 Mar;16(3):1122-30. doi: 10.1200/JCO.1998.16.3.1122. J Clin Oncol. 1998. PMID: 9508199 Clinical Trial.

6

Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx.

Siu LL, Czaykowski PM, Tannock IF. Siu LL, et al. J Clin Oncol. 1998 Jul;16(7):2514-21. doi: 10.1200/JCO.1998.16.7.2514. J Clin Oncol. 1998. PMID: 9667272 Clinical Trial.

7

Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming units.

Siu LL, Attardo G, Izbicka E, Lawrence R, Cerna C, Gomez L, Davidson K, Finkle C, Marsolais C, Rowinsky EK, Von Hoff DD. Siu LL, et al. Ann Oncol. 1998 Aug;9(8):885-91. doi: 10.1023/a:1008387019062. Ann Oncol. 1998. PMID: 9789612

8

Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors.

Patnaik A, Warner E, Michael M, Egorin MJ, Moore MJ, Siu LL, Fracasso PM, Rivkin S, Kerr I, Litchman M, Oza AM. Patnaik A, et al. Among authors: siu ll. J Clin Oncol. 2000 Nov 1;18(21):3677-89. doi: 10.1200/JCO.2000.18.21.3677. J Clin Oncol. 2000. PMID: 11054441 Clinical Trial.

9

Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies.

Hidalgo M, Siu LL, Nemunaitis J, Rizzo J, Hammond LA, Takimoto C, Eckhardt SG, Tolcher A, Britten CD, Denis L, Ferrante K, Von Hoff DD, Silberman S, Rowinsky EK. Hidalgo M, et al. Among authors: siu ll. J Clin Oncol. 2001 Jul 1;19(13):3267-79. doi: 10.1200/JCO.2001.19.13.3267. J Clin Oncol. 2001. PMID: 11432895 Clinical Trial.

10

Impact of the media and the internet on oncology: survey of cancer patients and oncologists in Canada.

Chen X, Siu LL. Chen X, et al. Among authors: siu ll. J Clin Oncol. 2001 Dec 1;19(23):4291-7. doi: 10.1200/JCO.2001.19.23.4291. J Clin Oncol. 2001. PMID: 11731511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results